Verrica Pharmaceuticals Inc.
Reports in 16d· 2026-05-13
-6.6% · 90d
$6.83
-0.16 (-2.22%)
After-Hours $6.83(+0.00)
News
(1)April 2026
Verrica seeks shareholder votes on board, pay, and stock plan amendments
VRCAVerrica Pharmaceuticals Inc.
# 📜 What This Document Is 🗓️ This document is a Proxy Statement (DEF 14A), which is essentially the company's official rulebook and agenda for its annual meeting of stockholders. It is not a financial results report, but rather a comprehensive legal filing that tells you exactly what decisions the
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%